Position in ARVN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,213
-$271 QoQ
Shares Held
146
+4.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#185
of 198 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026True Wealth Design, LLC holds $1,417,706 across 151 Biotechnology names. ARVN ranks #90 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,850 | $209,716 | |
| 2 | EXEL |
Exelixis, Inc.
|
2,973 | $161,760 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
210 | $130,943 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,644 | $92,179 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
173 | $85,934 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
320 | $77,110 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
957 | $54,759 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
529 | $45,996 |
All Filings in ARVN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,213 | 146 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,484 | 140 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,304 | 110 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $911 | 107 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $22 | 3 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $161 | 23 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||